RE:RE:RE:RE:RE:RE:RE:Dr. Jean-Pierre BizzariOur company is testing a reovirus. Only 1 oncolytic reovirus has ever been approved to fight cancer in 1 indication, melanoma. We are building our case to be the 2nd in at least 2 indications. Results have been great, missteps have been made but the trajectory, over time, has been forward. Mistakes in R&D in any industry are not corrected quickly, never mind years long studies and extensive regulatory input in the medical field. Maybe we need a switch up on the board, maybe we should ask for accountability for past failures, maybe you guys write the company and make your case rather than whinge on here everyday.
Science takes a long time. Especially when you're trying to produce a product that isn't widely used in fighting cancer, but is producing strong efficacious results.
Our board and Advisors are beasts. They're not attaching their name to a failing, untruthful or unscrupulous company. It makes zero sense for them to be attached to us for any other reason than we're getting Pela to market.
It's your impatience that is the problem. We're getting there, slowly but surely and this guys addition to the ranks "affirms" that!!!!